Jazz Pharmaceuticals’ $7.2-billion purchase of GW Pharmaceuticals last week is the biggest tie-up yet for the cannabis industry. And it’s probably just the beginning. The blockbuster deal, which dwarfs Tilray Inc. and Aphria Inc.’s $3.8-billion merger as well as Constellation Brands Inc.’s multibillion-dollar investment in Canopy Growth Corp., shows the growing interest... Read more

Eight years ago, Washington staked a claim as the first state, along with Colorado, to legalize recreational marijuana use. More than a dozen states have since followed suit. But Washington’s status as a legalization pioneer has lagged in one respect: It remains a felony to grow marijuana for recreational use... Read more